The Walter and Eliza Hall Institute of Medical Research-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:The Walter and Eliza Hall Institute of Medical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013241
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Walter and Eliza Hall Institute of Medical Research (WEHI), a subsidiary of Melbourne Medical School The University of Melbourne is a medical research institute that conducts clinical research, and offers educational and contract research services. The institute develops therapeutics for the prevention and treatment of diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. It provides undergraduate, PhD, honors, and other programs. WEHI performs research in various fields such as bioinformatics, cancer biology, cell death, cell signaling, clinical translation, immunology, infection, inflammation, medicinal chemistry, stem cells, structural biology, systems biology and vaccine development. The institute operates through WEHI biotechnology center located in Bundoora, Australia. WEHI is headquartered in Parkville, Victoria, Australia.

The Walter and Eliza Hall Institute of Medical Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
The Walter and Eliza Hall Institute of Medical Research, Medical Devices Deals, 2011 to YTD 2017 9
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Servier Enters into Research Agreement with Walter and Eliza Hall Institute of Medical Research 11
ImmusanT Enters Into Research Agreement With Walter and Eliza Hall Institute of Medical Research 12
Licensing Agreements 13
TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research 13
The Walter and Eliza Hall Institute of Medical Research – Key Competitors 14
The Walter and Eliza Hall Institute of Medical Research – Key Employees 15
The Walter and Eliza Hall Institute of Medical Research – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Nov 14, 2017: World Diabetes Day: funding boost for diabetes research 17
Nov 10, 2017: Short-circuiting dangerous immune cells to treat asthma 19
Nov 18, 2016: New quality control revealed in immune T cell development 20
May 17, 2016: Researchers reveal how a new class of drugs kills cancer cells 21
Feb 19, 2016: 3D protein map offers new malaria vaccine hope 22
Feb 19, 2016: Scientists discover secret to promising new cancer drug 23
Feb 12, 2016: Gene technology to help healthy skin in Aboriginal Australians 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Key Facts 2
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The Walter and Eliza Hall Institute of Medical Research, Deals By Therapy Area, 2011 to YTD 2017 8
The Walter and Eliza Hall Institute of Medical Research, Medical Devices Deals, 2011 to YTD 2017 9
The Walter and Eliza Hall Institute of Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Servier Enters into Research Agreement with Walter and Eliza Hall Institute of Medical Research 11
ImmusanT Enters Into Research Agreement With Walter and Eliza Hall Institute of Medical Research 12
TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research 13
The Walter and Eliza Hall Institute of Medical Research, Key Competitors 14
The Walter and Eliza Hall Institute of Medical Research, Key Employees 15
The Walter and Eliza Hall Institute of Medical Research, Other Locations 16

★海外企業調査レポート[The Walter and Eliza Hall Institute of Medical Research-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Occidental Petroleum Corporation (OXY)-エネルギー分野:企業M&A・提携分析
    Summary Occidental Petroleum Corporation (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream and marketing; and chemicals business. The oil and gas business explores for, develops and produc …
  • GVK Power and Infrastructure Ltd (GVKPIL):企業の財務・戦略的SWOT分析
    GVK Power and Infrastructure Ltd (GVKPIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • NXT Energy Solutions Inc (SFD):石油・ガス:M&Aディール及び事業提携情報
    Summary NXT Energy Solutions Inc (NXT Energy), formerly Energy Exploration Technologies Inc is an oilfield service company that offers geophysical services to the upstream oil and gas industry. The company provides Stress Field Detection (SFD) a patent pending gravity-based instrument that provides …
  • Jiangsu Jumpcan Pharmaceutical Group Co Ltd (600566):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiangsu Jumpcan Pharmaceutical Group Co Ltd (Jiangsu Jumpcan Pharma) is a developer, manufacturer and distributor of Chinese traditional medicine, Western medicine, daily use chemicals and healthcare products. The company offers its products in various therapeutic segments such as detoxifica …
  • Momenta Pharmaceuticals Inc (MNTA):企業の財務・戦略的SWOT分析
    Momenta Pharmaceuticals Inc (MNTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Dollarama Inc:戦略・SWOT・企業財務分析
    Dollarama Inc - Strategy, SWOT and Corporate Finance Report Summary Dollarama Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Neurocrine Biosciences Inc (NBIX)-製薬・医療分野:企業M&A・提携分析
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …
  • Republic Services, Inc.:企業の戦略・SWOT・財務情報
    Republic Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Republic Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • InsuLine Medical Ltd (INSL)-医療機器分野:企業M&A・提携分析
    Summary InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company’s products include InsuPad and InsuPatch. Its InsuPad is a patch for syringes and insulin pens; and InsuPatch is …
  • The Mosaic Company:企業の戦略・SWOT・財務情報
    The Mosaic Company - Strategy, SWOT and Corporate Finance Report Summary The Mosaic Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Green Energy Options Ltd:企業の戦略的SWOT分析
    Green Energy Options Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • ALK-Abello AS.:企業の戦略・SWOT・財務情報
    ALK-Abello AS. - Strategy, SWOT and Corporate Finance Report Summary ALK-Abello AS. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Singapore Telecommunications Ltd:企業の戦略・SWOT・財務情報
    Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Linklaters Llp
    Linklaters Llp - Strategy, SWOT and Corporate Finance Report Summary Linklaters Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • DS Smith Plc:企業のM&A・事業提携・投資動向
    DS Smith Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DS Smith Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • The Dixie Group Inc:企業の戦略・SWOT・財務情報
    The Dixie Group Inc - Strategy, SWOT and Corporate Finance Report Summary The Dixie Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Imperial Oil Limited:企業の戦略・SWOT・財務分析
    Imperial Oil Limited - Strategy, SWOT and Corporate Finance Report Summary Imperial Oil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hypera SA:企業の戦略・SWOT・財務情報
    Hypera SA - Strategy, SWOT and Corporate Finance Report Summary Hypera SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • The York Water Co (YORW):企業の財務・戦略的SWOT分析
    The York Water Co (YORW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Insightra Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Insightra Medical Inc (Insightra Medical), a subsidiary of GPB Life Science Holdings LLC is a medical device company that develops disposable devices. The company offers cardiovascular and surgical solutions. Its cardiovascular solutions include Ultra 7FR IAB and modulare. The Modulare Cathe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆